Latest
Phase 2 Study of CPX-351 Results Promising in Relapsed Pediatric AML
Prescription Drug Monitoring Programs May Prevent Patients With Cancer From Receiving Pain Management Therapy
Mepolizumab Gets Priority Review for Hypereosinophilic Syndrome
ETV6 Sequencing Important Among Patients With Inherited Thrombocytopenia, Malignancy
Emapalumab Effective for Pediatric Primary Hemophagocytic Lymphohistiocytosis
Preliminary Evidence Supports Benefit of Urinary-Derived hCG in Acute GVHD
Outcomes With Hemophagocytic Lymphohistiocytosis in Pediatric Patients
Real-World Data Suggest Prolonged Lenalidomide Maintenance Therapy Is Beneficial in Patients With MRD-Positive Multiple Myeloma
Real-World Data Back Efficacy of Axi-Cel in R/R DLBCL
Study Links DLBCL and CLL Incidence to Race and Ethnicity, Urban Status
Novel Therapies Needed: Poor Prognosis of Patients With TP53-Mutated Myeloid Malignancies
von Willebrand Disease False Levels, Misdiagnosis Still an Issue With Off-Site Testing
Featured Content
Navigating COVID-19: Self-Care Strategies for Oncology Professionals
A review of techniques oncology nurses can use to help themselves cope with their feelings as they navigate through the effects of the COVID-19 pandemic on their practice, their patients, and themselves.
Financial Burden of Childhood Cancer Treatment on Parents
Families affected by the emotional burden of childhood cancer often face significant financial difficulty due treatment expenses and time away from work.
Social Workers Are Underutilized in Oncologic Pain Management
Expertise in the use of nonpharmacologic pain management techniques and therapies allow masters-prepared social workers to be an integral member of a multidisciplinary cancer care team.
ASH 2020 Clinical Guidelines: Sickle Cell Disease and Cerebrovascular Disease
ASH published new clinical guidelines on the prevention, diagnosis, and treatment of CNS complications for children and adults with sickle cell disease.
Clotting and COVID: New Guidelines in the Works to Treat Coagulopathies in Patients With COVID-19
Growing concerns about thromboembolic comorbidities in patients with COVID-19 is leading ASH to create clinical practice guidelines to treat this patient population.
